Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ZIVO Bioscience, Inc. (ZIVO : OTC)
 
 • Company Description   
Zivo Bioscience Inc., is a R&D firm. It engaged in study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains. Zivo Bioscience Inc. is headquartered in Keego Harbor, Michigan.

Number of Employees: 7

 
 • Price / Volume Information   
Yesterday's Closing Price: $13.50 Daily Weekly Monthly
20 Day Moving Average: 309 shares
Shares Outstanding: 3.81 (millions)
Market Capitalization: $51.48 (millions)
Beta: -0.06
52 Week High: $22.15
52 Week Low: $5.80
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -3.50% -7.12%
12 Week -15.62% -29.03%
Year To Date -37.21% -41.20%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2125 BUTTERFIELD DRIVE SUITE 100
-
TROY,MI 48084
USA
ph: 248-452-9866
fax: -
tpatel@lhai.com http://www.zivobioscience.com
 
 • General Corporate Information   
Officers
John B. Payne - Chief Executive Officer; President and Director
Keith R. Marchiando - Chief Financial Officer; and Secretary
Christopher D. Maggiore - Director
Nola E. Masterson - Director
Alison A. Cornell - Director

Peer Information
ZIVO Bioscience, Inc. (CORR.)
ZIVO Bioscience, Inc. (RSPI)
ZIVO Bioscience, Inc. (CGXP)
ZIVO Bioscience, Inc. (BGEN)
ZIVO Bioscience, Inc. (GTBP)
ZIVO Bioscience, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 98978N309
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 3.81
Most Recent Split Date: 10.00 (0.17:1)
Beta: -0.06
Market Capitalization: $51.48 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -138.30%
vs. Previous Quarter: -211.11%
Sales Growth
vs. Year Ago Period: 650.00%
vs. Previous Quarter: 181.25%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -1,613.15
12/31/24 - -1,516.17
Current Ratio
06/30/25 - -
03/31/25 - 0.39
12/31/24 - 0.80
Quick Ratio
06/30/25 - -
03/31/25 - 0.39
12/31/24 - 0.80
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -13,375.41
12/31/24 - -8,513.55
Book Value
06/30/25 - -
03/31/25 - -0.42
12/31/24 - -0.14
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©